Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1980 Oct;64(10):766–769. doi: 10.1136/bjo.64.10.766

Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.

L M Collum, A Benedict-Smith, I B Hillary
PMCID: PMC1043813  PMID: 7000171

Abstract

The results of a randomised double-blind clinical trial of 3% acyclovir and 0.5% idoxuridine (IDU) ophthalmic ointments in 60 patients with corneal dendritic ulceration are presented. Ulcers in all 30 patients treated with acyclovir healed compared with 22 (76%) of 29 patients treated with IDU (P < 0.01). Patients treated with acyclovir healed more rapidly (average 4.4 days) than those who received IDU (average 9.2 days) (P < 0.01). No serious side effects were observed, though transient stinging was recorded in 8 patients receiving acyclovir and in 2 patients receiving IDU. Other side effects in the IDU treated group were watering in 2 patients and superficial punctate erosions in 6 patients.

Full text

PDF
769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURNS R. P. A DOUBLE-BLIND STUDY OF IDU IN HUMAN HERPES SIMPLEX KERATITIS. Arch Ophthalmol. 1963 Sep;70:381–384. doi: 10.1001/archopht.1963.00960050383020. [DOI] [PubMed] [Google Scholar]
  2. Blake J., Browne M. Treatment of herpetic keratitis. Doc Ophthalmol. 1977 Sep 30;44(1):23–33. doi: 10.1007/BF00171452. [DOI] [PubMed] [Google Scholar]
  3. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HART D. R., BRIGHTMAN V. J., READSHAW G. G., PORTER G. T., TULLY M. J. TREATMENT OF HUMAN HERPES SIMPLEX KERATITIS WITH IDOXURIDINE. Arch Ophthalmol. 1965 May;73:623–634. doi: 10.1001/archopht.1965.00970030625006. [DOI] [PubMed] [Google Scholar]
  5. Jones B. R., Coster D. J., Fison P. N., Thompson G. M., Cobo L. M., Falcon M. G. Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet. 1979 Feb 3;1(8110):243–244. doi: 10.1016/s0140-6736(79)90769-4. [DOI] [PubMed] [Google Scholar]
  6. KAUFMAN H., MARTOLA E. L., DOHLMAN C. Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis. Arch Ophthalmol. 1962 Aug;68:235–239. doi: 10.1001/archopht.1962.00960030239015. [DOI] [PubMed] [Google Scholar]
  7. LAIBSON P. R., LEOPOLD I. H. AN EVALUATION OF DOUBLE-BLIND IDU THERAPY IN 100 CASES OF HERPETIC KERATITIS. Trans Am Acad Ophthalmol Otolaryngol. 1964 Jan-Feb;68:22–34. [PubMed] [Google Scholar]
  8. Markham R. H., Carter C., Scobie M. A., Metcalf C., Easty D. L. Double--blind clinical trial of adenine arabinoside and idoxuridine in herpetic corneal ulcers. Trans Ophthalmol Soc U K. 1977 Jul;97(2):333–340. [PubMed] [Google Scholar]
  9. O'Meara A., Deasy P. F., Hillary I. B., Bridgen W. D. Acyclovir for treatment of mucocutaneous herpes infection in a child with leukaemia. Lancet. 1979 Dec 1;2(8153):1196–1196. doi: 10.1016/s0140-6736(79)92428-0. [DOI] [PubMed] [Google Scholar]
  10. PATTERSON A., FOX A. D., DAVIES G., MAGUIRE C., HOLMESSELLERS P. J., WRIGHT P., RICE N. S., COBB B., JONES B. R. CONTROLLED STUDIES OF IDU IN THE TREATMENT OF HERPETIC KERATITIS. Trans Ophthalmol Soc U K. 1963;83:583–591. [PubMed] [Google Scholar]
  11. Patterson A., Jones B. R. The management of ocular herpes. Trans Ophthalmol Soc U K. 1967;87:59–84. [PubMed] [Google Scholar]
  12. Pavan-Langston D., Campbell R., Lass J. Acyclic antimetabolite therapy of experimental herpes simplex keratitis. Am J Ophthalmol. 1978 Nov;86(5):618–623. doi: 10.1016/0002-9394(78)90178-2. [DOI] [PubMed] [Google Scholar]
  13. Pavan-Langston D., Dohlman C. H. A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Am J Ophthalmol. 1972 Jul;74(1):81–88. doi: 10.1016/0002-9394(72)91130-0. [DOI] [PubMed] [Google Scholar]
  14. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978 Apr 13;272(5654):583–585. doi: 10.1038/272583a0. [DOI] [PubMed] [Google Scholar]
  15. Selby P. J., Powles R. L., Janeson B., Kay H. E., Watson J. G., Thornton R., Morgenstern G., Clink H. M., McElwain T. J., Prentice H. G. Parenteral acyclovir therapy for herpesvirus infections in man. Lancet. 1979 Dec 15;2(8155):1267–1270. doi: 10.1016/s0140-6736(79)92281-5. [DOI] [PubMed] [Google Scholar]
  16. Wellings P. C., Awdry P. N., Bors F. H., Jones B. R., Brown D. C., Kaufman H. E. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol. 1972 Jun;73(6):932–942. doi: 10.1016/0002-9394(72)90463-1. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES